The next-generation DNA and/or RNA sequencing approach has led to the identification of RET fusion in a variety of cancers, including colorectal, breast, ovarian, and salivary gland cancers, as well as Spitz tumors and chronic myeloproliferative neoplasms (29), (30), (31). The gene discussed is RET; the disease is cancer.